Literature DB >> 15680818

Long-term assessment of mitral valve reconstruction with resection of the leaflets: triangular and quadrangular resection.

Yoshimasa Sakamoto1, Kazuhiro Hashimoto, Hiroshi Okuyama, Shinichi Ishii, Makoto Hanai, Takahiro Inoue, Gen Shinohara, Kiyozo Morita, Hiromi Kurosawa.   

Abstract

BACKGROUND: The procedure of quadrangular resection and suture for prolapsed posterior leaflet of the mitral valve is a reliable and reproducible method that achieves excellent long-term results. However, triangular resection and suture of a prolapsed anterior leaflet is not widely supported and different techniques have been advocated. The aim of this study was to review our experience of mitral valve repair in which resection of the anterior and/or posterior leaflets was performed.
METHODS: Between October 1991 and September 2003, 105 patients with mitral regurgitation underwent mitral valve reconstruction with leaflet resection, including 55 patients with quadrangular resection of the posterior leaflet (P), 32 patients with triangular resection of the anterior leaflet (A), and 18 patients with resection of both leaflets (A+P).
RESULTS: The mean follow-up period was 63.6 (1 to 139) months. Reoperation was required in 2 patients, each after resection of the anterior or posterior leaflet. The freedom from reoperation rates at 10 years in 93% +/- 5% of patients after triangular resection of the anterior leaflet, 96% +/- 3% after quadrangular resection of the posterior leaflet, and 100% after resection of both leaflets. There were no significant differences of survival or risk of reoperation among these three groups. The postoperative mitral valve area was significantly smaller than the preoperative area in all three groups, but remained large enough (A: 2.84 +/- 1.07; P: 2.6 +/- 0.87; A+P: 3.09 +/- 1.20 cm2) for adequate valve function.
CONCLUSIONS: Triangular resection of a prolapsed anterior mitral leaflet is a reliable, reproducible, and durable procedure, like quadrangular resection of a prolapsed posterior leaflet.

Entities:  

Mesh:

Year:  2005        PMID: 15680818     DOI: 10.1016/j.athoracsur.2004.07.046

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Chordal Reconstruction versus Leaflet Resection for Repair of Degenerative Posterior Mitral Leaflet Prolapse.

Authors:  Yeow Leng Chua; Philip Y K Pang; Yen Ping Yap; Zakir Hussain Abdul Salam; Yang Tian Chen
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-12-25       Impact factor: 1.520

Review 2.  Computational mitral valve evaluation and potential clinical applications.

Authors:  Krishnan B Chandran; Hyunggun Kim
Journal:  Ann Biomed Eng       Date:  2014-08-19       Impact factor: 3.934

Review 3.  Beginning and development of surgery for acquired valvular heart disease in Japan.

Authors:  Kazuhiro Hashimoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

4.  Midterm results of mitral valve repair with the Carpentier-Edwards rigid ring.

Authors:  Yoshimasa Sakamoto; Kazuhiro Hashimoto; Hiroshi Okuyama; Shinichi Ishii; Shingo Taguchi; Hiroshi Kagawa; Michio Yoshitake
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-02

5.  Three-dimensional echocardiography-based prediction of posterior leaflet resection.

Authors:  Yonghoon Rim; Ahnryul Choi; Susan T Laing; David D McPherson; Hyunggun Kim
Journal:  Echocardiography       Date:  2014-08-11       Impact factor: 1.724

6.  Personalized Computational Modeling of Mitral Valve Prolapse: Virtual Leaflet Resection.

Authors:  Yonghoon Rim; Ahnryul Choi; David D McPherson; Hyunggun Kim
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

7.  Targeted triangular resection for repair of degenerative mitral valve disease.

Authors:  Daniel J P Burns; Rakesh M Suri; A Marc Gillinov
Journal:  JTCVS Tech       Date:  2021-10-02

8.  Mitral valve repair: the chordae tendineae.

Authors:  Carlos-A Mestres; José M Bernal
Journal:  J Tehran Heart Cent       Date:  2012-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.